p53, known as “the guardian of the genome”, regulates cell division and prevents tumor formation by controlling the cell cycle and DNA repair machinery, and p53 replacement therapy has shown potent anti-tumor effects in preclinical and clinical studies [35, 36]. The gene discussed is TP53; the disease is neoplasm.